Protalix BioTherapeutics
PLX
#8915
Rank
$0.13 B
Marketcap
$1.73
Share price
-1.14%
Change (1 day)
2.37%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2025 (TTM): -$0.04000

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is -$0.04000. In 2024 the company made an earnings per share (EPS) of $0.04000 a decrease over its 2023 EPS that were of $0.12.

EPS history for Protalix BioTherapeutics from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-$0.04000-200%
2024$0.04000-66.67%
2023$0.12-138.71%
2022-$0.31-50%
2021-$0.62181.82%
2020-$0.22-82.11%
2019-$1.23-31.67%
2018-$1.80-72.31%
2017-$6.50124.14%
2016-$2.90-147.54%
2015$6.10-290.63%
2014-$3.206.67%
2013-$3.00130.77%
2012-$1.30-69.77%
2011-$4.3019.44%
2010-$3.60-12.2%
2009-$4.1036.67%
2008-$3.00-37.5%
2007-$4.8050%
2006-$3.203.23%
2005-$3.10138.46%
2004-$1.30-74%
2003-$5.000%
2002-$5.00-50%
2001-$10.00233.33%
2000-$3.00-84.21%
1999-$19.00-24%
1998-$25.00-600%
1997$5.00-16.67%
1996$6.00

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amicus Therapeutics
FOLD
-$0.11 175.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
$4.31-10,875.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$1.72-4,400.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$0.63-1,675.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel